Apatinib as First -Line Treatment for Advanced Esophagus Cancer
NCT03542422
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Advanced Esophagus Cancer
Interventions
DRUG:
Apatinib
Sponsor
Affiliated Hospital of North Sichuan Medical College